The limited sample size of the investigation inhibited a comparison of serum chloride levels between euglycemic diabetic ketoacidosis patients utilizing SGLT2 inhibitors and those not utilizing them. The gene discussed is SLC5A2; the disease is diabetic ketoacidosis.